Diagnostic antibodies and antigens for Neurodegenerative diseases (Alzheimer Disease (AD)) testing: p-tau181, p-tau217, p-tau231, Tau, NFL, GFAP, Aβ42, Aβ40, albumin, Aβ38, HFABP, MCP-1, neurogranin, NSE, sTREM2, VLP-1, YKL-40, α-synuclein, AD7c-NTP
Neurodegenerative diseases refer to the injury or dysfunction of one or more nerves, which results in numbness, tingling, muscle weakness and discomfort in the nerves affected part. Alzheimer's disease (AD) is a progressive neurodegenerative disease most often characterized by initial memory impairment and cognitive decline that can ultimately affect behavior, speech, visuospatial orientation and the motor system, and it is the most common form of dementia. Peripheral neuropathy refers the injury or dysfunction of the peripheral nerves. Peripheral neuropathy might be acute or chronic, and sometimes it is reversible. Biochemical markers are increasingly used for the early diagnosis of the neuropathy. In addition, such markers may provide additional information for understanding the pathology of disease.
Several markers such as a Phospho-tau181 (p-tau181), Phospho-tau217 (p-tau217)
, Phospho-tau231 (p-tau231)
, tau proteins (Tau), neurofilament light chain (NFL), Glial fibrillary acid protein (GFAP), beta-amyloid 42 (Aβ42), beta-amyloid 40 (Aβ40), AD-associated neuaronal thread protein (AD7c-NTP) and so on have been identified to be associated with the neurodegenerative diseases. Evidence has shown plasma biomarkers (p-tau181, p-tau217, p-tau231, GFAP, NfL and Aβ42/40) were significantly changed in preclinical Alzheimer Disease (AD). Detecting the quantity of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Evidence has shown plasma biomarkers (p-tau181, p-tau217, p-tau231, GFAP, NfL, and Aβ42/40) were significantly changed in preclinical Alzheimer's Disease (AD). Recently, our R&D department demonstrated that our GMP-h-p-tau217-Ab01 has a large linear range and good sensitivity against the GMP-h-p-tau217-Ag01. Below is the result of GeneMedi's GMP-h-p-tau217-Ab01 (Anti-human p-tau217 antibody) validation with GMP-h-p-tau217-Ag01 (p-tau217 antigen) in ELISA. We highly recommend the Ab&Ag to you.
Figure 1. GeneMedi's GMP-h-p-tau217-Ab01 (Anti-human p-tau217 antibody) is validated to detect the GMP-h-p-tau217-Ag01 (p-tau217 antigen) in ELISA. EC50 = 25.85ng/ml.
Classification: p-tau181 p-tau217 p-tau231 Tau NFL GFAP Aβ42 Aβ40 albumin Aβ38 HFABP MCP-1 neurogranin NSE sTREM2 VLP-1 YKL-40 α-synuclein AD7c-NTP
The most recommended pair antibody and antigen
Pair Antibody and Antigen | Products detail | Cat.No | Size | Order |
P-tau217 | 1. Antigen | 1. GMP-h-p-tau217-Ag01 | 1mg | Inquiry to get a 20% coupon for the package |
2. Capture antibody | 2. GMP-h-p-tau217-Ab01 | 1mg | ||
3. Detector antibody | 3. GMP-h-Tau-Ab03 | 1mg | ||
P-tau181 | 1. Antigen | 1. GMP-h-p-tau181-Ag01 | 1mg | Inquiry to get a 20% coupon for the package |
2. Capture antibody | 2. GMP-h-p-tau181-Ab01 | 1mg | ||
3. Detector antibody | 3. GMP-h-Tau-Ab03 | 1mg | ||
P-tau231 | 1. Antigen | 1. GMP-h-p-tau231-Ag01 | 1mg | Inquiry to get a 20% coupon for the package |
2. Capture antibody | 2. GMP-h-p-tau231-Ab01 | 1mg | ||
3. Detector antibody | 3. GMP-h-Tau-Ab03 | 1mg |
Phospho-tau181 (p-tau181)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-p-tau181 | Human | Phospho-tau181 (p-tau181) | Alzheimer Disease(AD) | GMP-h-p-tau181-Ag01: Phospho-tau181 (p-tau181) antigen |
Phospho-tau181 (p-tau181) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in p-tau181 level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-p-tau181-Ab01; GMP-h-p-tau181-Ab02: Anti-human p-tau181 mouse monoclonal antibody(mAb) |
Human Phospho-tau181 (p-tau181) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Phospho-tau181 (p-tau181) antibodies in p-tau181 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Phospho-tau217 (p-tau217)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-p-tau217 | Human | Phospho-tau217 (p-tau217) | Alzheimer Disease(AD) | GMP-h-p-tau217-Ag01: Phospho-tau217 (p-tau217) antigen |
Phospho-tau217 (p-tau217) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in p-tau217 level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-p-tau217-Ab01; GMP-h-p-tau217-Ab02: Anti-human p-tau217 mouse monoclonal antibody(mAb) |
Human Phospho-tau217 (p-tau217) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Phospho-tau217 (p-tau217) antibodies in p-tau217 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Phospho-tau231 (p-tau231)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-p-tau231 | Human | Phospho-tau231 (p-tau231) | Alzheimer Disease(AD) | GMP-h-p-tau231-Ag01: Phospho-tau231 (p-tau231) antigen |
Phospho-tau231 (p-tau231) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in p-tau231 level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-p-tau231-Ab01; GMP-h-p-tau231-Ab02: Anti-human p-tau231 mouse monoclonal antibody(mAb) |
Human Phospho-tau231 (p-tau231) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Phospho-tau231 (p-tau231) antibodies in p-tau231 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
tau proteins (Tau)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Tau | Human | tau proteins (Tau) | Alzheimer Disease(AD) | GMP-h-Tau-Ag01: Recombinant human Tau Protein |
tau proteins (Tau) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Tau level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-Tau-Ab01; GMP-h-Tau-Ab02; GMP-h-Tau-Ab03: Anti-human Tau mouse monoclonal antibody(mAb) |
Human tau proteins (Tau) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other tau proteins (Tau) antibodies in Tau level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
neurofilament light chain (NFL)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-NFL | Human | neurofilament light chain (NFL) | Alzheimer Disease(AD) | GMP-h-NFL-Ag01: Recombinant human NFL Protein |
neurofilament light chain (NFL) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in NFL level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-NFL-Ab01; GMP-h-NFL-Ab02: Anti-human NFL mouse monoclonal antibody(mAb) |
Human neurofilament light chain (NFL) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other neurofilament light chain (NFL) antibodies in NFL level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Glial fibrillary acid protein (GFAP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-GFAP | Human | Glial fibrillary acid protein (GFAP) | Alzheimer Disease(AD) | GMP-h-GFAP-Ag01: Recombinant human GFAP Protein |
Glial fibrillary acid protein (GFAP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in GFAP level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-GFAP-Ab01; GMP-h-GFAP-Ab02: Anti-human GFAP mouse monoclonal antibody(mAb) |
Human Glial fibrillary acid protein (GFAP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Glial fibrillary acid protein (GFAP) antibodies in GFAP level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
beta-amyloid 42 (Aβ42)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Aβ42 | Human | beta-amyloid 42 (Aβ42) | Alzheimer Disease(AD) | GMP-h-Aβ42-Ag01: Recombinant human Aβ42 Protein |
beta-amyloid 42 (Aβ42) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Aβ42 level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-Aβ42-Ab01; GMP-h-Aβ42-Ab02: Anti-human Aβ42 mouse monoclonal antibody(mAb) |
Human beta-amyloid 42 (Aβ42) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 42 (Aβ42) antibodies in Aβ42 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
beta-amyloid 40 (Aβ40)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Aβ40 | Human | beta-amyloid 40 (Aβ40) | Alzheimer Disease(AD) | GMP-h-Aβ40-Ag01: Recombinant human Aβ40 Protein |
beta-amyloid 40 (Aβ40) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in Aβ40 level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-Aβ40-Ab01; GMP-h-Aβ40-Ab02: Anti-human Aβ40 mouse monoclonal antibody(mAb) |
Human beta-amyloid 40 (Aβ40) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 40 (Aβ40) antibodies in Aβ40 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
albumin protein (albumin)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-albumin | Human | albumin protein (albumin) | Alzheimer Disease(AD) | GMP-h-albumin-Ag01: Recombinant Human albumin Protein |
albumin protein (albumin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in albumin level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-albumin-Ab01; GMP-h-albumin-Ab02: Anti-Human albumin mouse monoclonal antibody (mAb) |
Human albumin protein (albumin) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other albumin protein (albumin) antibodies in albumin level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
beta-amyloid 38 (Aβ38)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-Aβ38 | Human | beta-amyloid 38 (Aβ38) | Alzheimer Disease(AD) | GMP-h-Aβ38-Ag01: Recombinant Human Aβ38 Protein |
beta-amyloid 38 (Aβ38) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Aβ38 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-Aβ38-Ab01; GMP-h-Aβ38-Ab02: Anti-Human Aβ38 mouse monoclonal antibody (mAb) |
Human beta-amyloid 38 (Aβ38) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 38 (Aβ38) antibodies in Aβ38 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Heart fatty acid-binding protein (HFABP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-HFABP | Human | Heart fatty acid-binding protein (HFABP) | Alzheimer Disease(AD) | GMP-h-HFABP-Ag01: Recombinant Human HFABP Protein |
Heart fatty acid-binding protein (HFABP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HFABP level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-HFABP-Ab01; GMP-h-HFABP-Ab02: Anti-Human HFABP mouse monoclonal antibody (mAb) |
Human Heart fatty acid-binding protein (HFABP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Heart fatty acid-binding protein (HFABP) antibodies in HFABP level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Monocyte chemoattractant protein-1 (MCP-1/CCL2)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-MCP-1 | Human | Monocyte chemoattractant protein-1 (MCP-1/CCL2) | Alzheimer Disease(AD) | GMP-h-MCP-1-Ag01: Recombinant Human MCP-1 Protein |
Monocyte chemoattractant protein-1 (MCP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MCP-1 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-MCP-1-Ab01; GMP-h-MCP-1-Ab02: Anti-Human MCP-1 mouse monoclonal antibody (mAb) |
Human Monocyte chemoattractant protein-1 (MCP-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Monocyte chemoattractant protein-1 (MCP-1) antibodies in MCP-1 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
neurogranin protein (neurogranin)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-neurogranin | Human | neurogranin protein (neurogranin) | Alzheimer Disease(AD) | GMP-h-neurogranin-Ag01: Recombinant Human neurogranin Protein |
neurogranin protein (neurogranin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in neurogranin level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-neurogranin-Ab01; GMP-h-neurogranin-Ab02: Anti-Human neurogranin mouse monoclonal antibody (mAb) |
Human neurogranin protein (neurogranin) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other neurogranin protein (neurogranin) antibodies in neurogranin level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
neuron-specific enolase (NSE)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-NSE | Human | neuron-specific enolase (NSE) | Alzheimer Disease(AD) | GMP-h-NSE-Ag01: Recombinant Human NSE Protein |
neuron-specific enolase (NSE) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in NSE level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-NSE-Ab01; GMP-h-NSE-Ab02: Anti-Human NSE mouse monoclonal antibody (mAb) |
Human neuron-specific enolase (NSE) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other neuron-specific enolase (NSE) antibodies in NSE level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-sTREM2 | Human | soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) | Alzheimer Disease(AD) | GMP-h-sTREM2-Ag01: Recombinant Human sTREM2 Protein |
soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in sTREM2 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-sTREM2-Ab01; GMP-h-sTREM2-Ab02: Anti-Human sTREM2 mouse monoclonal antibody (mAb) |
Human soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antibodies in sTREM2 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Visinin-like protein 1 (VLP-1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-VLP-1 | Human | Visinin-like protein 1 (VLP-1) | Alzheimer Disease(AD) | GMP-h-VLP-1-Ag01: Recombinant Human VLP-1 Protein |
Visinin-like protein 1 (VLP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VLP-1 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-VLP-1-Ab01; GMP-h-VLP-1-Ab02: Anti-Human VLP-1 mouse monoclonal antibody (mAb) |
Human Visinin-like protein 1 (VLP-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Visinin-like protein 1 (VLP-1) antibodies in VLP-1 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Chitinase-3-like protein 1 (CHI3L1/YKL-40)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-YKL-40 | Human | Chitinase-3-like protein 1 (CHI3L1/YKL-40) | Alzheimer Disease(AD) | GMP-h-YKL-40-Ag01: Recombinant Human YKL-40 Protein |
Chitinase-3-like protein 1 (YKL-40) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in YKL-40 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-YKL-40-Ab01; GMP-h-YKL-40-Ab02: Anti-Human YKL-40 mouse monoclonal antibody (mAb) |
Human Chitinase-3-like protein 1 (YKL-40) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Chitinase-3-like protein 1 (YKL-40) antibodies in YKL-40 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
Alpha-synuclein (α-synuclein)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-α-synuclein | Human | Alpha-synuclein (α-synuclein) | Alzheimer Disease (AD), Parkinson's disease |
GMP-h-α-synuclein-Ag01: Recombinant Human α-synuclein Protein |
Alpha-synuclein (α-synuclein) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in α-synuclein level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation | GMP-h-α-synuclein-Ab01; GMP-h-α-synuclein-Ab02: Anti-Human α-synuclein mouse monoclonal antibody (mAb) |
Human Alpha-synuclein (α-synuclein) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Alpha-synuclein (α-synuclein) antibodies in α-synuclein level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |
AD-associated neuaronal thread protein (AD7c-NTP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-AD7c-NTP | Human | AD-associated neuaronal thread protein (AD7c-NTP) | Alzheimer Disease(AD) | GMP-h-AD7c-NTP-Ag01: Recombinant human AD7c-NTP Protein |
AD-associated neuaronal thread protein (AD7c-NTP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in AD7c-NTP level test of Neurodegenerative diseases(Alzheimer Disease(AD)) and related syndrome evaluation. | GMP-h-AD7c-NTP-Ab01; GMP-h-AD7c-NTP-Ab02: Anti-human AD7c-NTP mouse monoclonal antibody(mAb) |
Human AD-associated neuaronal thread protein (AD7c-NTP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other AD-associated neuaronal thread protein (AD7c-NTP) antibodies in AD7c-NTP level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. | ![]() |